Amwins has rebranded its Group Benefits division as Amwins Benefits.
The change reflects what the firm describes as a more integrated approach for retail brokers, carrier partners, third-party administrators (TPAs) and consultants.
Under the refresh, the Group Benefits businesses are being organized into clearly defined solution verticals that Amwins said will be easier for partners to navigate.
Amwins Connect will now be marketed as Amwins Benefit | Small to Mid-Market, with True Benefit folded into this vertical while retaining its own brand. Meanwhile, Stealth Partner Group will be marketed as Amwins Benefits | Self-Funded; James R. Nelligan & Associates as Amwins Benefits | Ancillary; the Amwins Group Benefits retiree practice as Amwins Benefits | Retiree Healthcare, and Amwins Accident & Health Underwriters as Amwins Benefits | Exclusive Programs.
The rebrand follows a multi-year build-out of the division through acquisitions and organic growth. Amwins has acquired several of these businesses over time, including True Benefit, a program manager focused on employee benefits for ADP TotalSource PEO clients, as well as ancillary specialist Nelligan. Stealth Partner Group has grown into a major stop-loss wholesaler and cost-containment partner for brokers and TPAs, while Amwins Accident & Health Underwriters brings together two long-standing managing general underwriters, Beacon Risk Strategies and Strategic Underwriting Solutions.
“By bringing our businesses together under the Amwins name and organizing our capabilities around solutions, we’re making it easier for our partners to access the expertise, products and market leverage they need to win,” said Riva Dumeny, president of Amwins Benefits. “We look forward to operating under a unified identity, strengthening collaboration across our businesses and continuing to lead the wholesale benefits market together as Amwins Benefits.”
The Group Benefits division has more than $11.1 billion in annual group benefits premium placements, with over 10.5 million lives covered and more than 1,200 employees nationwide.
The newly branded Amwins Benefits division now presents its offerings across five solution verticals: small to mid-market, self-funded, ancillary, retiree healthcare and exclusive programs.
In 2024, Amwins Group Benefits expanded its gene therapy solutions program from five to 15 gene and cell therapies, using a partnership between Stealth Partner Group and Amwins Accident & Health Underwriters to help employer plans manage the financial impact of high-cost treatments. That type of specialty capability now sits under the Amwins Benefits umbrella.
The rebrand comes as group health and benefits markets continue to grapple with medical cost inflation that is outpacing general inflation and reshaping employer funding strategies.
In its own 2026 state-of-the-market commentary, Amwins highlights how medical cost drivers and healthcare-specific trends are pushing more mid-sized employers toward self-funded and alternative funding arrangements, increasing demand for stop loss, cost-containment tools and specialized advisory support.
Against that backdrop, the clearer segmentation of Amwins Benefits into small to mid-market, self-funded and ancillary verticals is likely to appeal to brokers who are balancing fully insured, level-funded and self-funded options across their books. Stealth’s self-funded and stop-loss focus, Nelligan’s ancillary expertise and True Benefit’s PEO program-management capabilities together give Amwins a broad platform across funding structures and benefit types.
